Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Targeted Lung Chemotherapy in the Treatment of Metastatic Tumors

NCT01014598 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT01014598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Targeted Lung Chemotherapy in the Treatment of Metastatic Tumors
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1
Overall status
Completed
Start date
December 4, 2007
Completion date
May 1, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the lung, stage iiib non-small cell lung cancer, stage iv adult soft tissue sarcoma, stage iv non-small cell lung cancer